BCL6 and B-cell non-Hodgkin lymphoma: In order to determine whether BCL6 binding occurs preferentially in accessible or inaccessible chromatin regions, binding sites were correlated to DNaseI hypersensitive sites (DHSs) in human B-cell lymphoma cells.